Related content

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

By Aristegui J.   Bernaola E.   Pocheville I.   García C.   Arranz L.   Durán G.   Pérez L.   Bastida M.   Canduela C.   Herranz Aguirre M.   Garrote E.   Fletcher M.   Pérez C.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 5, 2007-05 ,pp. : 303-310

Springer Publishing Company

Access to resources Recommend Favorite

Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010

By Demczuk Walter H.B.   Martin Irene   Griffith Averil   Lefebvre Brigitte   McGeer Allison   Shane Amanda   Zhanel George G.   Tyrrell Gregory J.   Gilmour Matthew W.      

Canadian Journal of Microbiology, Vol. 58, Iss. 8, 2012-08 ,pp. : 1008-1017

NRC Research Press

Access to resources Recommend Favorite

Pneumococcal meningitis in childhood: a longitudinal prospective study

By Pagliano Pasquale   Fusco Ugo   Attanasio Vittorio   Rossi Marco   Pantosti Annalisa   Conte Marco   Faella Francesco Saverio  

FEMS Immunology & Medical Microbiology, Vol. 51, Iss. 3, 2007-12 ,pp. : 488-495

Blackwell Publishing

Access to resources Recommend Favorite

Serotype-specific problems associated with pneumococcal conjugate vaccination

By Hanage William P  

Future Microbiology, Vol. 3, Iss. 1, 2008-02 ,pp. : 23-30

Future Medicine

Access to resources Recommend Favorite

Development and Evaluation of Pneumococcal Conjugate Vaccines: Clinical Trials and Control Tests

By Lee Lucia H.   Lee Chi-Jen   Frasch Carl E.  

Critical Reviews in Microbiology, Vol. 28, Iss. 1, 2002-01 ,pp. : 27-41

Informa Healthcare

Access to resources Recommend Favorite